MTVA
MetaVia Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 10:52:35 AM EST
1.07USD-0.926%(-0.01)44,847
Pre-marketNov 19, 2026 9:19:30 AM EST
1.133USD+4.907%(+0.053)
Loading…
Loading…
7.38M
Previous Close
$1.06
Beta
1.41
52-Week High
$13.42 2025-12-08
52-Week Low
$0.97 2026-05-12
SMA 50
$1.42
SMA 200
$1.59
Avg. Vol 10D
311,254
Avg. Vol 30D
153,956
Avg. Vol 90D
107,923
Relative Vol
0.24
6.74M
4.80M
71.25%
56,090
1.17%
1.00
33%/67%
24.69%
15.40%
32.5100%
250,000
35
1,185
2,785
Dec 5, 2025 · 1-for-11 (reverse)
-15.7M
-16.6M
Nov 18, 2026
Nov 17, 2026
MetaVia completes phase 1 trial of liver disease drug DA-1726 ·
Investing.com
Nov 16, 2026
MTVA Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.30 | 2026-11-12 | -15.77% | -1.221 |
| 1M | 1.23 | 2026-10-19 | -10.98% | 3.586 |
| 3M | 1.47 | 2026-08-19 | -25.51% | 2.996 |
| 6M | 1.88 | 2026-05-19 | -41.76% | 1.967 |
| 1Y | 8.40 | 2025-11-19 | -86.97% | 1.408 |
| 2Y | 28.05 | 2024-11-29 | -96.10% | — |
MTVA Stock Summary
MetaVia Inc. Common Stock (NASDAQ:MTVA) stock price today is $1.10, and today's volume is 37,347. MTVA is up 3.302% today. The 30 day average volume is 153,956. MTVA market cap is $7.38M with 6.74M shares outstanding.